Literature DB >> 10072307

Cortical ablation induces a spreading calcium-dependent, secondary pathogenesis which can be reduced by inhibiting calpain.

R T Bartus1, E Y Chen, G Lynch, J H Kordower.   

Abstract

Many forms of acute brain injury are associated with a secondary, glutamate- and calcium-dependent cascade which greatly exacerbates the final damage. The calcium-dependent protease, calpain, has been implicated as an important variable in this pathogenic process. The present studies tested (i) if similar secondary degeneration occurs following surgical ablation of a discrete area within rat visual cortex, (ii) if activation of calpain contributes to the secondary degeneration by spreading into areas adjacent to the ablation, and (iii) if blocking calpain's proteolytic effects reduces the secondary degeneration attendant to the lesion. Antibodies selective for a protein fragment specifically generated by calpain were used to map areas in which the protease had been activated. Labeling was present 5 min after surgery in a narrow zone surrounding the ablated region. The volume of the immunopositive staining increased twofold within 24 h and fivefold by 48 h, at which time it was equivalent in size to the original lesion. This staining pattern significantly decreased in size at 5 days postsurgery. Application of calpain inhibitors to the ablation site immediately after surgery reduced the spread of calpain activation by approximately 80%. Following cortical ablation, the volume of the lateral geniculate nucleus ipsilateral to the cortical ablation shrank by 46 +/- 3% in control rats but only by 31 +/- 5% in animals given the calpain inhibitors. These results establish that (i) a secondary degenerative cascade is unleashed following discrete cortical surgery which expands into brain areas clearly outside the initial perturbation site, (ii) the gradual expansion of calpain activation contributes to the underlying secondary pathology, and (iii) blocking calpain activity substantially reduces atrophy in areas anatomically connected, but physically distal to the damaged zone. The possible utility of topical applications of calpain inhibitors, or analogously acting drugs, in minimizing the secondary effects of brain surgery is discussed. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072307     DOI: 10.1006/exnr.1998.7001

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  5 in total

1.  Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.

Authors:  Isaac O Donkor; Rajani Korukonda
Journal:  Bioorg Med Chem Lett       Date:  2008-07-27       Impact factor: 2.823

2.  Cytochrome c release and caspase activation in traumatic axonal injury.

Authors:  A Büki; D O Okonkwo; K K Wang; J T Povlishock
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

Review 3.  The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states.

Authors:  P W Vanderklish; B A Bahr
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

4.  JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration.

Authors:  Vincent Ries; Robert M Silva; Tinmarla F Oo; Hsiao-Chun Cheng; Margarita Rzhetskaya; Nikolai Kholodilov; Richard A Flavell; Chia-Yi Kuan; Pasko Rakic; Robert E Burke
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

Review 5.  Regulatory role of calpain in neuronal death.

Authors:  Si-Ying Cheng; Shu-Chao Wang; Ming Lei; Zhen Wang; Kun Xiong
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.